Blood samples may reveal targets for personalized cancer vaccines without a tumor biopsy
A post says a new study shows it is possible to identify the antigens needed for personalized neoantigen vaccines using a blood sample rather than a tumor biopsy.
TLDR
The post says personalized neoantigen vaccines have been shown to improve outcomes in refractory malignant melanoma and in pilot studies of pancreatic cancer, glioblastoma, renal cell carcinoma and triple-negative breast cancer. It says a new study shows the antigens needed for the vaccines can be identified from a blood sample instead of a tumor biopsy.
Combined views
9K
1 Source, first seen 3h ago